Calumet (CLMT) EBIT (2023 - 2026)

Calumet (CLMT) has reported EBIT for 4 consecutive years, with -$40.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT rose 60.4% year-over-year to -$40.0 million in Q2 2026; TTM through Jun 2026 was $47.1 million, a 125.58% increase from a year earlier, with the FY2025 full-year figure at $108.7 million, up 1241.98% from the prior year.
• EBIT was -$40.0 million for Q2 2026 at Calumet, up from -$171.3 million in the prior quarter.
• Over five years, EBIT peaked at $322.9 million in Q3 2025 and troughed at -$171.3 million in Q1 2026.
• A 4-year average of $10.0 million and a median of -$13.9 million in 2023 frame the typical range for EBIT.
• The widest YoY moves for EBIT: up 665.5% in 2025, down 1729.03% in 2025.
• Over 4 years, EBIT stood at -$13.9 million in 2023, then soared by 263.31% to $22.7 million in 2024, then tumbled by 384.14% to -$64.5 million in 2025, then surged by 37.98% to -$40.0 million in 2026.
• The last three EBIT figures came in at -$40.0 million (Q2 2026), -$171.3 million (Q1 2026), and -$64.5 million (Q4 2025), per Business Quant data.